Microsatellite instability and Epstein-Barr virus infection in gastric remnant cancers.
Clinicopathological analysis, microsatellite analysis, detection of Epstein-Barr virus (EBV), and immunohistochemistry on p53 protein were performed in 26 cases of gastric remnant cancer (GRC). They were divided into two groups; Group A (n = 14) who had undergone a primary gastrectomy for benign gastric disease, and Group B (n = 12) who had undergone the same operation for gastric cancer. EBV infection was present in 29% of Group A, 8% of Group B and 6% of the conventional gastric carcinoma (CGC) (Group A vs CGC, P = 0.01). Microsatellite instability (MSI) was found in 7% of Group A, 25% of Group B, and 9% of the CGC (Group B vs CGC; P = 0.08). p53 Overexpression was observed in 46% of the GRC and 33% of the CGC. p53 Overexpression was observed in 90% of the intestinal type of GRC, but in only 20% of the diffuse type of GRC (P = 0.002). The cancer stage was a significant factor in the univariate analysis of survival (P = 0.04). In conclusion, GRC is different from CGC in terms of MSI or EBV association. The pathogenetic differences between the two groups require further investigation. EBV infection may have been involved in the carcinogenesis of Group A. MSI may be an important factor in the carcinogenesis of metachronous multiple gastric cancer (Group B).
Chang
M S
MS
Departments of Pathology andSurgery, Seoul National University College of Medicine, Seoul, Korea.
Lee
J H
JH
Kim
J P
JP
Kim
H S
HS
Lee
H S
HS
Kim
C W
CW
Kim
Y I
YI
Kim
W H
WH
D000328:Adult; D000368:Aged; D004273:DNA, Neoplasm / Q000235:genetics; D004279:DNA, Viral / Q000235:genetics; D020031:Epstein-Barr Virus Infections / Q000235:genetics* / Q000473:pathology / Q000821:virology; D005260:Female; D018530:Gastric Stump; D004854:Herpesvirus 4, Human / Q000235:genetics; D006801:Humans; D007150:Immunohistochemistry; D017403:In Situ Hybridization; D008297:Male; D018895:Microsatellite Repeats / Q000235:genetics*; D008875:Middle Aged; D009367:Neoplasm Staging; D012367:RNA, Viral / Q000235:genetics; D013270:Stomach / Q000737:chemistry / Q000473:pathology / Q000821:virology; D013274:Stomach Neoplasms / Q000235:genetics* / Q000473:pathology / Q000821:virology; D016159:Tumor Suppressor Protein p53 / Q000032:analysis
D004273:DNA, Neoplasm; D004279:DNA, Viral; D012367:RNA, Viral; D016159:Tumor Suppressor Protein p53